The Regulatory Role of Vα14 NKT Cells in Innate and Acquired Immune Response
Masaru Taniguchi;Michishige Harada;Satoshi Kojo;Toshinori Nakayama.
Annual Review of Immunology (2003)
993 Citations
Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity
Omid Akbari;Philippe Stock;Everett Meyer;Mitchell Kronenberg.
Nature Medicine (2003)
835 Citations
Activation of natural killer T cells by α -galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes
Shayan Sharif;Guillermo A. Arreaza;Peter Zucker;Qing-Sheng Mi.
Nature Medicine (2001)
745 Citations
A Phase I Study of α-Galactosylceramide (KRN7000)–Pulsed Dendritic Cells in Patients with Advanced and Recurrent Non–Small Cell Lung Cancer
Aki Ishikawa;Shinichiro Motohashi;Eiichi Ishikawa;Hiroki Fuchida.
Clinical Cancer Research (2005)
571 Citations
Natural Killer T Cell Ligand α-Galactosylceramide Enhances Protective Immunity Induced by Malaria Vaccines
Gloria Gonzalez-Aseguinolaza;Luc Van Kaer;Cornelia C. Bergmann;James M. Wilson.
Journal of Experimental Medicine (2002)
390 Citations
Requirement for natural killer T (NKT) cells in the induction of allograft tolerance.
Ken-ichiro Seino;Katashi Fukao;Kenzo Muramoto;Kazuhiko Yanagisawa.
Proceedings of the National Academy of Sciences of the United States of America (2001)
348 Citations
A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity
Asuka Terashima;Hiroshi Watarai;Sayo Inoue;Etsuko Sekine.
Journal of Experimental Medicine (2008)
331 Citations